UnknownNot Applicable

Excisional Vacuum-Assisted Breast Biopsy

Italy300 participantsStarted 2023-01-17

Plain-language summary

The goal of this prospective cohort study is to evaluate the possibility of vacuum-assisted excisional biopsy (VAE) to completely remove the pathology in case of small lesions for Atypical Ductal Hyperplasia (ADH) and low-intermediate grade Ductal Carcinoma in Situ (DCIS).

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with suspicious breast lesions (BIRADS \>3) * Patients with a lesion \<= of 15mm. * Capable and willing to comply the specific informed consent form * Patients with ADH biopsy results or low intermediate-grade DCIS * Patients who will undergo surgery Exclusion Criteria: \- Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study

What they're measuring

Percentage of patients with complete removal of lesion

Timeframe: 6 months

Trial details

NCT IDNCT05932758

SponsorEuropean Institute of Oncology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-30

Contact for this trial

Luca Nicosia, MD

+390294372449 luca.nicosia@ieo.it

View on ClinicalTrials.gov More Atypical Ductal Hyperplasia trials